Market closedADR
Valneva/$VALN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Valneva
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
Ticker
$VALN
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
713
Website
Valneva Metrics
BasicAdvanced
$557M
-
-$0.10
1.29
-
Price and volume
Market cap
$557M
Beta
1.29
52-week high
$8.20
52-week low
$5.74
Average daily volume
100K
Financial strength
Current ratio
2.61
Quick ratio
1.776
Long term debt to equity
106.455
Total debt to equity
119.343
Interest coverage (TTM)
-3.21%
Management effectiveness
Return on assets (TTM)
-10.03%
Return on equity (TTM)
-7.91%
Valuation
Price to revenue (TTM)
5.051
Price to book
2.64
Price to tangible book (TTM)
3.04
Price to free cash flow (TTM)
-10.239
Growth
Revenue change (TTM)
10.32%
Earnings per share change (TTM)
-88.51%
3-year revenue growth (CAGR)
-21.31%
3-year earnings per share growth (CAGR)
-51.83%
Valneva News
AllArticlesVideos
Valneva Provides Update on Recommendation for Use of Its Chikungunya Vaccine by French Authorities
GlobeNewsWire·1 week ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN
GlobeNewsWire·2 weeks ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN
GlobeNewsWire·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Valneva stock?
Valneva (VALN) has a market cap of $557M as of May 06, 2025.
What is the P/E ratio for Valneva stock?
The price to earnings (P/E) ratio for Valneva (VALN) stock is 0 as of May 06, 2025.
Does Valneva stock pay dividends?
No, Valneva (VALN) stock does not pay dividends to its shareholders as of May 06, 2025.
When is the next Valneva dividend payment date?
Valneva (VALN) stock does not pay dividends to its shareholders.
What is the beta indicator for Valneva?
Valneva (VALN) has a beta rating of 1.29. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.